The Polyvalent Role of CD30 for Cancer Diagnosis and Treatment
CD30, also known as TNFRSF8 (tumor necrosis factor receptor superfamily member 8), is a protein receptor that is heavily glycosylated inside the Golgi apparatus, as well as a tumor marker that is found on the surface of specific cells in the body, including certain immune cells and cancer ones. This...
Main Authors: | Adrian Vasile Dumitru, Dana Antonia Țăpoi, Georgian Halcu, Octavian Munteanu, David-Ioan Dumitrascu, Mihail Constantin Ceaușu, Ancuța-Augustina Gheorghișan-Gălățeanu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-07-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/12/13/1783 |
Similar Items
-
THE STANDARD OF CARE IN RELAPSED REFRACTORY CD30+ LYMPHOMA
by: Martin Hutchings
Published: (2014-07-01) -
CD30: receptor, marker, target
by: Gottesman SRS
Published: (2016-06-01) -
Breast implant-associated anaplastic large cell lymphoma in an Asian patient: The first case report from Thailand
by: Peera Thienpaitoon, et al.
Published: (2020-09-01) -
Brentuximab vedotin in children and adolescents with Hodgkin’s lymphoma and anaplastic large cell lymphoma – literature review and own experience
by: N. V. Myakova, et al.
Published: (2016-03-01) -
Story of survival in anaplastic large cell lymphoma - sometimes more than the anaplastic lymphoma kinase status: An evaluation of pathologic prognostic factors in 102 cases
by: Komal Agrawal, et al.
Published: (2017-01-01)